Navigation Links
EGTA, Molecular Biology Grade from Research Organics, Inc.
...loped the Easy-Titer Human IgM Assay Kit to addres...rform assay for Human IgM that eliminates the need...and-read assay that allows the accurate determinat...oximately 30 minutes. The Pierce Easy-Titer Human ...
...ilizer is an aqueous solution that contains a puri...g chemicals in a saline solution, pH 6.5 7.5, and...ne and 0.02% bromonitrodioxane as a preservative. ...bilizer for biologically active components in solu...
Cleanascite HC 16000 from Biotech Support Group
...e Stabilizer is a bovine protein-free alternative ...ueous solution that contains non-toxic chemicals i... - 7.2, and does not contain a preservative. This...other biomolecules that are absorbed or immobilize...
Biology Products:
(Date:11/23/2009)...of General Medical Sciences (NIGMS), part of the N...42.3 million for grants in scientific areas it ide...ed the GO grant program to stimulate biomedical re... American Recovery and Reinvestment Act (Recovery ...e to have a significant impact on a field of biome...
(Date:11/23/2009)...aled how environmental irritants such as air pollu... research published today in the American Journal...uthors of the study, from Imperial College London ...action inside the lungs that can trigger coughing ...n the air. They suggest that their findings may ul...
(Date:11/23/2009)...asty business, posing dangers to human health and ...s launching a new project with funding from the U....ets the fat and grease that contribute to millions...ners new tools to further reduce the risk of sewag...y" sewer systems, as opposed to "combined" systems...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research reveals exactly how coughing is triggered by environmental irritants 2Lose the fat: Targeting grease to curtail sewer overflows 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 1Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 3Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 4Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 5Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 6Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 7CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 1CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 2Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 1Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 2
...n human stem cell research, producing embryonic-li...ly speed up the development of treatments for life... The discovery made during a project undertaken wi...anch and the Synthecon Corporation in the United S...with an ethical and reliable source of human stem ...
...e US could soon be asked to approve a human trial ...brid of the HIV and Ebola viruses. Tests on monkey...s far more efficiently than any other method devel...iller viruses sounds horrifying, the risks should ...to develop an effective form of gene therapy to tr...
...sed on a recently published article in Environment...teria and a newly discovered group of marine worms...h uses sunken marine mammals as its sole source of...tal Microbiology, Dr Shana Goffredi and her collea...ia and the Osedax (bone-devouring) group of marine...
Other Biology News:Researchers propose measures to curb lion attacks in Tanzania 2Can two killers make a cure? 2
(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
(Date:11/19/2009)...-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), a...er to its shareholders, discussing the Company,s a...aceuticals Holdings, Inc. (CHBP), an integrated bi...ublic of China. The merger gives NeoStem a control.... Ltd., CHBP,s primary operating subsidiary and a ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4